Wolverine Trading
PDLI

Wolverine Trading’s PDL BioPharma, Inc. PDLI Stock Holding History

Wolverine Trading’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-17,903
Closed -$53K – 6534
2018
Q2 		$53K Hold
17,903
– – ﹤0.01% 4899
2018
Q1 		$53K Buy
17,903
+5,473
+44% +$14.9K ﹤0.01% 4899
2017
Q4 		$34K Buy
12,430
+1,787
+17% +$5.49K ﹤0.01% 4652
2017
Q3 		$36K Buy
+10,643
New +$29.6K ﹤0.01% 4275
2016
Q4 		– Sell
-11,125
Closed -$31K – 5750
2016
Q3 		$36K Buy
+11,125
New +$35.3K ﹤0.01% 4451

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return